Scott H. Gillis is President of Pericor Science, Inc. and also an independent consultant with more than 40 years' experience in the pharmaceutical and medical device industry in capacities ranging from sales and marketing positions to general management. He has extensive experience in the fields of dermatology, anti-infectives, cardiology, oncology, psychiatry, orthopedics, dentistry, drug delivery and wound care products. His experience includes the advancement of medical ideas from research and development to commercial products, securing financing, and negotiating sales, marketing and distribution partnerships with major healthcare corporations.
Prior to becoming President at Pericor Science, Inc. and consulting, Mr. Gillis served as President and CEO of NUCRYST Pharmaceuticals, Inc. for 8 years. He took NUCRYST public on the NASDAQ and TSX in 2005. Mr. Gillis also served as President and CEO of Li Medical, a private medical device company, for 5 years. Prior to Li Medical, Mr. Gillis spent 15 years at Bristol-Myers Squibb where he worked in a number of divisions including Squibb, Westwood, Mead Johnson Pharmaceuticals, ConvaTec and Mead Johnson Oncology. At ConvaTec, he served as Vice President and General Manager of ConvaTec USA and later as Global Vice President, Wound and Skin Care.
A Boston native, Mr. Gillis has an MBA from Xavier University and a BA in Biology and Chemistry from Salem State College.